pharma · Relapsed/Refractory Diffuse Large B-cell Lymphoma · Non-muscle invasive bladder cancer (NMIBC)
Shanghai Antengene Corporation
Shanghai Antengene Corporation Limited
NovaPharmaNews editorial coverage mentioning Shanghai Antengene Corporation — regulatory, clinical, and market analysis.
SAINT-LAURENT, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAINT-LAURENT, CN
- Programs
- 3
- Drugs
- 8
- Patents
- 53
News & analysis
NovaPharmaNews articles mentioning Shanghai Antengene Corporation — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Shanghai Antengene Corporation — regulatory, clinical, and market analysis.